{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:40:17Z","timestamp":1778866817387,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10557-024-07618-5","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T02:02:01Z","timestamp":1725069721000},"page":"1021-1032","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Low Thyroid Hormones Level Attenuates Mitochondrial Dysfunction and Right Ventricular Failure in Pulmonary Hypertensive Rats"],"prefix":"10.1007","volume":"39","author":[{"given":"Natalia Soares Carvalho","family":"Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thais","family":"Barenco-Marins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raiana Andrade Quintanilha","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano Gon\u00e7alves","family":"Ponte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4772-5618","authenticated-orcid":false,"given":"Fernando Azevedo Cruz","family":"Seara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emerson Lopes","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Hamilton Matheus","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,31]]},"reference":[{"issue":"8","key":"7618_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","volume":"8","author":"RT Schermuly","year":"2011","unstructured":"Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F. Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol. 2011;8(8):443\u201355. https:\/\/doi.org\/10.1038\/nrcardio.2011.87.","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"7618_CR2","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/eurheartj\/ehl477","volume":"28","author":"SA Van Wolferen","year":"2007","unstructured":"Van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J. 2007;28(10):1250\u20137. https:\/\/doi.org\/10.1093\/eurheartj\/ehl477.","journal-title":"Eur Heart J"},{"key":"7618_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ijcard.2016.05.015","volume":"218","author":"MJ Brewis","year":"2016","unstructured":"Brewis MJ, Bellofiore A, Vanderpool RR, et al. Imaging right ventricular function to predict outcome in pulmonary arterial hypertension. Int J Cardiol. 2016;218:206\u201311. https:\/\/doi.org\/10.1016\/j.ijcard.2016.05.015.","journal-title":"Int J Cardiol"},{"issue":"3","key":"7618_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1378\/chest.07-0366","volume":"132","author":"JH Li","year":"2007","unstructured":"Li JH, Safford RE, Aduen JF, et al. Pulmonary hypertension and thyroid disease. Chest. 2007;132(3):793\u20137. https:\/\/doi.org\/10.1378\/chest.07-0366.","journal-title":"Chest"},{"issue":"5","key":"7618_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0002-9629(15)40640-8","volume":"318","author":"AL Curnock","year":"1999","unstructured":"Curnock AL, Dweik RD, Higgins BH, Saadi HF, Arroliga AC. High prevalence of hypothyroidism in patients with primary pulmonary hypertension. Am J Med Sci. 1999;318(5):289\u201392. https:\/\/doi.org\/10.1016\/S0002-9629(15)40640-8.","journal-title":"Am J Med Sci"},{"issue":"5","key":"7618_CR6","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1378\/chest.122.5.1668","volume":"122","author":"JW Chu","year":"2002","unstructured":"Chu JW, Kao PN, Faul JL, Doyle RL. High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest. 2002;122(5):1668\u201373. https:\/\/doi.org\/10.1378\/chest.122.5.1668.","journal-title":"Chest"},{"issue":"12","key":"7618_CR7","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.healun.2016.05.022","volume":"35","author":"MJ Richter","year":"2016","unstructured":"Richter MJ, Sommer N, Schermuly R, et al. The prognostic impact of thyroid function in pulmonary hypertension. J Hear Lung Transplant. 2016;35(12):1427\u201334. https:\/\/doi.org\/10.1016\/j.healun.2016.05.022.","journal-title":"J Hear Lung Transplant"},{"issue":"9","key":"7618_CR8","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1253\/circj.CJ-10-0270","volume":"74","author":"Y Miura","year":"2010","unstructured":"Miura Y, Fukumoto Y, Sugimura K, et al. Identification of new prognostic factors of pulmonary hypertension. Circ J. 2010;74(9):1965\u201371. https:\/\/doi.org\/10.1253\/circj.CJ-10-0270.","journal-title":"Circ J"},{"issue":"5","key":"7618_CR9","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1210\/jc.2006-1877","volume":"92","author":"C-W Siu","year":"2007","unstructured":"Siu C-W, Zhang X-H, Yung C, Kung AWC, Lau C-P, Tse H-F. hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. J Clin Endocrinol Metab. 2007;92(5):1736\u201342. https:\/\/doi.org\/10.1210\/jc.2006-1877.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"7618_CR10","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1210\/endo.143.7.8985","volume":"143","author":"FWJS Wassen","year":"2002","unstructured":"Wassen FWJS, Schiel AE, Kuiper GGJM, et al. Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. Endocrinology. 2002;143(7):2812\u20135. https:\/\/doi.org\/10.1210\/endo.143.7.8985.","journal-title":"Endocrinology"},{"key":"7618_CR11","doi-asserted-by":"publisher","unstructured":"Al Husseini A, Bagnato G, Farkas L, et al. Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats. Eur Respir J Eur Respir Soc. 2013;41(1):104\u201314. https:\/\/doi.org\/10.1183\/09031936.00196511","DOI":"10.1183\/09031936.00196511"},{"issue":"10","key":"7618_CR12","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1210\/en.2007-0043","volume":"148","author":"EL Olivares","year":"2007","unstructured":"Olivares EL, Marassi MP, Fortunato RS, et al. Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats\u2014a time course study. Endocrinology. 2007;148(10):4786\u201392. https:\/\/doi.org\/10.1210\/en.2007-0043.","journal-title":"Endocrinology"},{"issue":"5","key":"7618_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1210\/me.2011-1325","volume":"26","author":"CB Ueta","year":"2012","unstructured":"Ueta CB, Oskouei BN, Olivares EL, et al. Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in mice. Mol Endocrinol. 2012;26(5):809\u201318. https:\/\/doi.org\/10.1210\/me.2011-1325.","journal-title":"Mol Endocrinol"},{"issue":"10","key":"7618_CR14","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20198491","volume":"52","author":"FAC Seara","year":"2019","unstructured":"Seara FAC, Araujo IG, Imp\u00e9rio GE, et al. Propranolol inhibits myocardial infarction-induced brown adipose tissue D2 activation and maintains a low thyroid hormone state in rats. Braz J Med Biol Res. 2019;52(10): e8491. https:\/\/doi.org\/10.1590\/1414-431x20198491.","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"7618_CR15","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1089\/thy.2016.0570","volume":"27","author":"AJ Wassner","year":"2017","unstructured":"Wassner AJ, Jugo RH, Dorfman DM, et al. Myocardial induction of type 3 deiodinase in dilated cardiomyopathy. Thyroid. 2017;27(5):732\u20137. https:\/\/doi.org\/10.1089\/thy.2016.0570.","journal-title":"Thyroid"},{"issue":"2","key":"7618_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1210\/en.2010-0431","volume":"152","author":"CJ Pol","year":"2011","unstructured":"Pol CJ, Muller A, Zuidwijk MJ, et al. Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition. Endocrinology. 2011;152(2):669\u201379. https:\/\/doi.org\/10.1210\/en.2010-0431.","journal-title":"Endocrinology"},{"key":"7618_CR17","doi-asserted-by":"publisher","unstructured":"Janssen R, Zuidwijk M, Muller A, et al. Cardiac expression of deiodinase type 3 (Dio3) following myocardial infarction is associated with the induction of a pluripotency microRNA signature from the Dlk1-Dio3 genomic region. Endocrinology. 2013;154(6):1973\u20131978.  https:\/\/doi.org\/10.1210\/en.2012-2017.","DOI":"10.1210\/en.2012-2017"},{"key":"7618_CR18","doi-asserted-by":"publisher","unstructured":"Seara FAC, Maciel L, Barbosa RAQ, et al. Cardiac ischemia\/reperfusion injury is inversely affected by thyroid hormones excess or deficiency in male Wistar rats. Calvert J, editor. PLoS One. 2018;13(1):e0190355. https:\/\/doi.org\/10.1371\/journal.pone.0190355","DOI":"10.1371\/journal.pone.0190355"},{"issue":"4","key":"7618_CR19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1749-6632.1951.tb54465.x","volume":"54","author":"HA Lardy","year":"1951","unstructured":"Lardy HA, Feldott G. Metabolic effects of thyroxine in vitro. Ann N Y Acad Sci. 1951;54(4):636\u201348. https:\/\/doi.org\/10.1111\/j.1749-6632.1951.tb54465.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"7618_CR20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00109-010-0679-1","volume":"88","author":"L Piao","year":"2010","unstructured":"Piao L, Marsboom G, Archer SL. Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure. J Mol Med. 2010;88(10):1011\u201320. https:\/\/doi.org\/10.1007\/s00109-010-0679-1.","journal-title":"J Mol Med"},{"issue":"1","key":"7618_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/CIRCHEARTFAILURE.111.966127","volume":"6","author":"J Gomez-Arroyo","year":"2013","unstructured":"Gomez-Arroyo J, Mizuno S, Szczepanek K, et al. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Circ Hear Fail. 2013;6(1):136\u201344. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.111.966127.","journal-title":"Circ Hear Fail"},{"issue":"1\u20132","key":"7618_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11010-012-1485-6","volume":"373","author":"I Enache","year":"2013","unstructured":"Enache I, Charles A-L, Bouitbir J, et al. Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension. Mol Cell Biochem. 2013;373(1\u20132):161\u201370. https:\/\/doi.org\/10.1007\/s11010-012-1485-6.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"7618_CR23","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cardiores.2007.05.012","volume":"75","author":"E Redout","year":"2007","unstructured":"Redout E, Wagner M, Zuidwijk M, et al. Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species. Cardiovasc Res. 2007;75(4):770\u201381. https:\/\/doi.org\/10.1016\/j.cardiores.2007.05.012.","journal-title":"Cardiovasc Res"},{"issue":"1\u20133","key":"7618_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ejphar.2013.01.050","volume":"702","author":"SL Pereira","year":"2013","unstructured":"Pereira SL, Kummerle AE, Fraga CAM, et al. A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension. Eur J Pharmacol. 2013;702(1\u20133):316\u201322. https:\/\/doi.org\/10.1016\/j.ejphar.2013.01.050.","journal-title":"Eur J Pharmacol"},{"key":"7618_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.steroids.2019.04.001","volume":"148","author":"FAC Seara","year":"2019","unstructured":"Seara FAC, Arantes PC, Domingos AE, et al. Cardiac electrical and contractile disorders promoted by anabolic steroid overdose are associated with late autonomic imbalance and impaired Ca2+ handling. Steroids. 2019;148:1\u201310. https:\/\/doi.org\/10.1016\/j.steroids.2019.04.001.","journal-title":"Steroids"},{"issue":"5","key":"7618_CR26","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/bph.12193","volume":"169","author":"AKN Alencar","year":"2013","unstructured":"Alencar AKN, Pereira SL, Montagnoli TL, et al. Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in rats. Br J Pharmacol. 2013;169(5):953\u201362. https:\/\/doi.org\/10.1111\/bph.12193.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"7618_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.5114\/aoms.2016.61789","volume":"2","author":"N Gedik","year":"2017","unstructured":"Gedik N, Maciel L, Schulte C, et al. Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning. Arch Med Sci. 2017;2(2):448\u201358. https:\/\/doi.org\/10.5114\/aoms.2016.61789.","journal-title":"Arch Med Sci"},{"key":"7618_CR28","doi-asserted-by":"publisher","unstructured":"Matta L, Fonseca TS, Faria CC, et al. The effect of acute aerobic exercise on redox homeostasis and mitochondrial function of rat white adipose tissue. Oxid Med Cell Longev. 2021;2021(1):1\u201315.  https:\/\/doi.org\/10.1155\/2021\/4593496. Bernardi M, editor.","DOI":"10.1155\/2021\/4593496"},{"issue":"1","key":"7618_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/thy.2013.0109","volume":"24","author":"AC Bianco","year":"2014","unstructured":"Bianco AC, Anderson G, Forrest D, et al. American Thyroid Association guide to investigating thyroid hormone economy and action in rodent and cell models. Thyroid. 2014;24(1):88\u2013168. https:\/\/doi.org\/10.1089\/thy.2013.0109.","journal-title":"Thyroid"},{"key":"7618_CR30","doi-asserted-by":"publisher","unstructured":"Sun C-K, Yuen C-M, Kao Y-H, et al. Propylthiouracil attenuates monocrotaline-induced pulmonary arterial hypertension in rats. Circ J. 2009;73(9):1722\u20131730. https:\/\/doi.org\/10.1253\/circj.CJ-09-0074.","DOI":"10.1253\/circj.CJ-09-0074"},{"issue":"4","key":"7618_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10557-020-07115-5","volume":"53","author":"AP Ferraz","year":"2021","unstructured":"Ferraz AP, Seara FAC, Baptista EF, et al. BKCa channel activation attenuates the pathophysiological progression of monocrotaline-induced pulmonary arterial hypertension in Wistar rats. Cardiovasc Drugs Ther. 2021;53(4):719\u201332. https:\/\/doi.org\/10.1007\/s10557-020-07115-5.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"7618_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejim.2005.11.023","volume":"17","author":"M Marvisi","year":"2006","unstructured":"Marvisi M, Zambrelli P, Brianti M, et al. Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. Eur J Intern Med. 2006;17(4):267\u201371. https:\/\/doi.org\/10.1016\/j.ejim.2005.11.023.","journal-title":"Eur J Intern Med"},{"issue":"11","key":"7618_CR33","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/01.RES.0000130784.90237.4a","volume":"94","author":"FB Davis","year":"2004","unstructured":"Davis FB, Mousa SA, O\u2019Connor L, et al. proangiogenic action of thyroid hormone is fibroblast growth factor\u2013dependent and is initiated at the cell surface. Circ Res. 2004;94(11):1500\u20136. https:\/\/doi.org\/10.1161\/01.RES.0000130784.90237.4a.","journal-title":"Circ Res"},{"issue":"1\u20133","key":"7618_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejphar.2011.07.002","volume":"669","author":"MA Oriowo","year":"2011","unstructured":"Oriowo MA, Oommen E, Khan I. Hyperthyroidism enhances 5-HT-induced contraction of the rat pulmonary artery: role of calcium-activated chloride channel activation. Eur J Pharmacol. 2011;669(1\u20133):108\u201314. https:\/\/doi.org\/10.1016\/j.ejphar.2011.07.002.","journal-title":"Eur J Pharmacol"},{"issue":"18","key":"7618_CR35","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.113.001873","volume":"128","author":"S Rain","year":"2013","unstructured":"Rain S, Handoko ML, Trip P, et al. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation. 2013;128(18):2016\u201325. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001873.","journal-title":"Circulation"},{"issue":"2","key":"7618_CR36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1378\/chest.125.2.572","volume":"125","author":"RJ Roeleveld","year":"2004","unstructured":"Roeleveld RJ, Vonk-Noordegraaf A, Marcus JT, et al. Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest. 2004;125(2):572\u20139. https:\/\/doi.org\/10.1378\/chest.125.2.572.","journal-title":"Chest"},{"issue":"2","key":"7618_CR37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jacc.2005.08.067","volume":"47","author":"SMJM Straus","year":"2006","unstructured":"Straus SMJM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47(2):362\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2005.08.067.","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"7618_CR38","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1161\/01.CIR.84.4.1516","volume":"84","author":"EG Schouten","year":"1991","unstructured":"Schouten EG, Dekker JM, Meppelink P, et al. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 1991;84(4):1516\u201323. https:\/\/doi.org\/10.1161\/01.CIR.84.4.1516.","journal-title":"Circulation."},{"key":"7618_CR39","doi-asserted-by":"publisher","unstructured":"Izumo S, Lompr\u00e9 AM, Matsuoka R, et al. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest. 1987;79(3):970\u2013977.  https:\/\/doi.org\/10.1172\/JCI112908.","DOI":"10.1172\/JCI112908"},{"issue":"6","key":"7618_CR40","doi-asserted-by":"publisher","first-page":"R1473","DOI":"10.1152\/ajpregu.00269.2003","volume":"285","author":"LW Hu","year":"2003","unstructured":"Hu LW, Benvenuti LA, Liberti EA, Carneiro-Ramos MS, Barreto-Chaves MLM. Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am J Physiol Integr Comp Physiol. 2003;285(6):R1473\u201380. https:\/\/doi.org\/10.1152\/ajpregu.00269.2003.","journal-title":"Am J Physiol Integr Comp Physiol."},{"issue":"1","key":"7618_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cardfail.2015.09.001","volume":"22","author":"AA Gupte","year":"2016","unstructured":"Gupte AA, Cordero-Reyes AM, Youker KA, et al. Differential mitochondrial function in remodeled right and nonremodeled left ventricles in pulmonary hypertension. J Card Fail. 2016;22(1):73\u201381. https:\/\/doi.org\/10.1016\/j.cardfail.2015.09.001.","journal-title":"J Card Fail"},{"issue":"4","key":"7618_CR42","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/0925-4439(91)90064-G","volume":"1096","author":"AM Das","year":"1991","unstructured":"Das AM, Harris DA. Control of mitochondrial ATP synthase in rat cardiomyocytes: effects of thyroid hormone. Biochim Biophys Acta - Mol Basis Dis. 1991;1096(4):284\u201390. https:\/\/doi.org\/10.1016\/0925-4439(91)90064-G.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"issue":"5","key":"7618_CR43","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1161\/01.RES.60.5.649","volume":"60","author":"LS Carter","year":"1987","unstructured":"Carter LS, Mueller RA, Norfleet EA, Payne FB, Saltzman LS. Hypothyroidism delays ischemia-induced contracture and adenine nucleotide depletion in rat myocardium. Circ Res. 1987;60(5):649\u201352. https:\/\/doi.org\/10.1161\/01.RES.60.5.649.","journal-title":"Circ Res"},{"key":"7618_CR44","doi-asserted-by":"publisher","first-page":"1322487","DOI":"10.3389\/fendo.2024.1322487","volume":"15","author":"O Sror-Turkel","year":"2024","unstructured":"Sror-Turkel O, El-Khatib N, Sharabi-Nov A, Avraham Y, Merchavy S. Low TSH and low T3 hormone levels as a prognostic for mortality in COVID-19 intensive care patients. Front Endocrinol. 2024;15:1322487. https:\/\/doi.org\/10.3389\/fendo.2024.1322487.","journal-title":"Front Endocrinol"},{"key":"7618_CR45","doi-asserted-by":"publisher","first-page":"1323994","DOI":"10.3389\/fendo.2024.1323994","volume":"15","author":"J-L Song","year":"2024","unstructured":"Song J-L, Hu J-W, Li L-R, et al. Association of thyroid autoimmunity with extra-thyroid diseases and the risk of mortality among adults: evidence from the NHANES. Front Endocrinol. 2024;15:1323994. https:\/\/doi.org\/10.3389\/fendo.2024.1323994.","journal-title":"Front Endocrinol"},{"issue":"15","key":"7618_CR46","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.3390\/nu14153043","volume":"14","author":"J Cho","year":"2022","unstructured":"Cho J, Park J, Yeom J, et al. Thyroid dysfunction and the effect of iodine-deficient parenteral nutrition in very low birth weight infants: a nationwide analysis of a Korean Neonatal Network Database. Nutrients. 2022;14(15):3043. https:\/\/doi.org\/10.3390\/nu14153043.","journal-title":"Nutrients"},{"issue":"4","key":"7618_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejim.2005.11.023","volume":"17","author":"LVM Araruna","year":"2022","unstructured":"Araruna LVM, de Oliveira DC, Pereira MC, et al. Interplay between thyroid hormone status and pulmonary hypertension in graves\u2019 disease: relevance of the assessment in thyrotoxic and euthyroid patients. Front Endocrinol. 2022;17(4):267\u201371. https:\/\/doi.org\/10.1016\/j.ejim.2005.11.023.","journal-title":"Front Endocrinol"},{"issue":"2","key":"7618_CR48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/jch.14152","volume":"23","author":"SS Jankauskas","year":"2021","unstructured":"Jankauskas SS, Morelli MB, Gambardella J, Lombardi A, Santulli G. Thyroid hormones regulate both cardiovascular and renal mechanisms underlying hypertension. J Clin Hypertens. 2021;23(2):373\u201381. https:\/\/doi.org\/10.1111\/jch.14152.","journal-title":"J Clin Hypertens"},{"key":"7618_CR49","doi-asserted-by":"publisher","first-page":"1192561","DOI":"10.3389\/fendo.2023.1192561","volume":"14","author":"L Croce","year":"2023","unstructured":"Croce L, Zampogna E, Coperchini F, et al. Thyroid hormones modifications among COVID-19 patients undergoing pulmonary rehabilitation. Front Endocrinol. 2023;14:1192561. https:\/\/doi.org\/10.3389\/fendo.2023.1192561.","journal-title":"Front Endocrinol"},{"issue":"1\u20132","key":"7618_CR50","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0303-7207(00)00302-6","volume":"168","author":"M L\u00f3pez-Torres","year":"2000","unstructured":"L\u00f3pez-Torres M, Romero M, Barja G. Effect of thyroid hormones on mitochondrial oxygen free radical production and DNA oxidative damage in the rat heart. Mol Cell Endocrinol. 2000;168(1\u20132):127\u201334. https:\/\/doi.org\/10.1016\/S0303-7207(00)00302-6.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"7618_CR51","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1210\/endo-121-6-2112","volume":"121","author":"K Asayama","year":"1987","unstructured":"Asayama K, Dobashi K, Hayashibe H, Megata Y, Kato K. Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism. Endocrinology. 1987;121(6):2112\u20138. https:\/\/doi.org\/10.1210\/endo-121-6-2112.","journal-title":"Endocrinology"},{"issue":"4","key":"7618_CR52","first-page":"149","volume":"52","author":"ES el Daly","year":"1997","unstructured":"el Daly ES. Effect of methimazole and fish oil treatment on gentamicin nephrotoxicity in rats. J Pharm Belg. 1997;52(4):149\u201356.","journal-title":"J Pharm Belg"},{"issue":"1","key":"7618_CR53","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0022-3565(25)11245-7","volume":"260","author":"PJ Sausen","year":"1992","unstructured":"Sausen PJ, Elfarra AA, Cooley AJ. Methimazole protection of rats against chemically induced kidney damage in vivo. J Pharmacol Exp Ther. 1992;260(1):393\u2013401.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"7618_CR54","doi-asserted-by":"publisher","first-page":"L363","DOI":"10.1152\/ajplung.00212.2011","volume":"302","author":"JG Gomez-Arroyo","year":"2012","unstructured":"Gomez-Arroyo JG, Farkas L, Alhussaini AA, et al. The monocrotaline model of pulmonary hypertension in perspective. Am J Physiol Cell Mol Physiol. 2012;302(4):L363\u20139. https:\/\/doi.org\/10.1152\/ajplung.00212.2011.","journal-title":"Am J Physiol Cell Mol Physiol"},{"issue":"1","key":"7618_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13293-020-00289-5","volume":"11","author":"O Rafikova","year":"2020","unstructured":"Rafikova O, James J, Eccles CA, et al. Early progression of pulmonary hypertension in the monocrotaline model in males is associated with increased lung permeability. Biol Sex Differ. 2020;11(1):11. https:\/\/doi.org\/10.1186\/s13293-020-00289-5.","journal-title":"Biol Sex Differ"},{"issue":"4","key":"7618_CR56","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/01.fjc.0000175878.32920.17","volume":"46","author":"SP Tofovic","year":"2005","unstructured":"Tofovic SP, Salah EM, Mady HH, Jackson EK, Melhem MF. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats. J Cardiovasc Pharmacol. 2005;46(4):430\u20137. https:\/\/doi.org\/10.1097\/01.fjc.0000175878.32920.17.","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07618-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-024-07618-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07618-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:23:18Z","timestamp":1762881798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-024-07618-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["7618"],"URL":"https:\/\/doi.org\/10.1007\/s10557-024-07618-5","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,31]]},"assertion":[{"value":"13 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}